Conditions: Type 2 Diabetes
Keywords: Diabetes Type 2 Diabetes
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 106
Healthy volunteers: no

Brief summary:
Study to evaluate the safety, tolerability and efficacy of LY2189102 in patients with type 2 diabetes.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None arm 4: 0.9% Sodium Chloride

Interventions: intervention 1: LY2189102 intervention 2: Placebo
Intervention descriptions: intervention 1: Participants received 2 subcutaneous (SC) injections weekly for 12 weeks. intervention 2: Participants received 2 SC injections weekly for 12 weeks.

Protocol document: